key: cord-0778681-02tw6upq
authors: Joly, E.; Maurel Ribes, A.
title: HAT-field: a very cheap, robust and quantitative point-of-care serological test for Covid-19.
date: 2022-01-14
journal: nan
DOI: 10.1101/2022.01.14.22268980
sha: 052f6750040ceb3b0639984b30f1e45f872318ec
doc_id: 778681
cord_uid: 02tw6upq

We have recently described a very simple and cheap serological test called HAT to detect antibodies directed against the RBD of the SARS-Cov-2 virus. HAT is based on hemagglutination, triggered by a single reagent (IH4-RBD) comprised of the viral RBD domain fused to a nanobody specific for glycophorin, which is expressed at very high levels at the surface of human red blood cells (RBCs). One of the main initial goals of this study was to devise a test protocol that would be sensitive and reliable, yet require no specialized laboratory equipment such as adjustable pipets, so that it could be performed in the most remote corners of the world by people with minimal levels of training. Because antibody levels against the viral RBD have been found to correlate closely with sero-neutralisation titers, and thus with protection against reinfection, it has become obvious during the course of this study that making this test reliably quantitative would be a further significant advantage. We have found that, in PBN, a buffer which contains BSA and sodium azide, IH4-RBD is stable for over 6 months at room temperature, and that PBN also improves HAT performance compared to using straight PBS. We also show that performing HAT at either 4{degrees}C, room temperature or 37{degrees}C has minimal influence on the results, and that quantitative evaluation of the levels of antibodies directed against the SARS-CoV-2 RBD can be achieved in a single step using titration of the IH4-RBD reagent. The HAT-field protocol described here requires only very simple disposable equipment and a few microliters of whole blood, such as can be obtained by finger prick. Because it is based on a single soluble reagent, the test can be adapted very simply and rapidly to detect antibodies against variants of the SARS-CoV-2, or conceivably against different pathogens. HAT-field appears well suited to provide quantitative assessments of the serological protection of populations as well as individuals, and given its very low cost, the stability of the IH4-RBD reagent in the adapted buffer, and the simplicity of the procedure, could be deployed pretty much anywhere, including in the poorest countries and the most remote corners of the globe.

Abstract 16 We have recently described a very simple and cheap serological test called HAT to detect 17 antibodies directed against the RBD of the SARS-Cov-2 virus. HAT is based on 18 hemagglutination, triggered by a single reagent (IH4-RBD) comprised of the viral RBD 19

domain fused to a nanobody specific for glycophorin, which is expressed at very high levels 20

at the surface of human red blood cells (RBCs). 21

One of the main initial goals of this study was to devise a test protocol that would be 22 sensitive and reliable, yet require no specialized laboratory equipment such as adjustable 23 pipets, so that it could be performed in the most remote corners of the world by people with 24 minimal levels of training. Because antibody levels against the viral RBD have been found to 25 correlate closely with sero-neutralisation titers, and thus with protection against reinfection, 26 it has become obvious during the course of this study that making this test reliably 27 quantitative would be a further significant advantage. 28 We have found that, in PBN, a buffer which contains BSA and sodium azide, IH4-RBD is 29 stable for over 6 months at room temperature, and that PBN also improves HAT 30 performance compared to using straight PBS. We also show that performing HAT at either 31 4°C, room temperature or 37°C has minimal influence on the results, and that quantitative 32 evaluation of the levels of antibodies directed against the SARS-CoV-2 RBD can be achieved 33 in a single step using titration of the IH4-RBD reagent. 34

The HAT-field protocol described here requires only very simple disposable equipment and a 35 few microliters of whole blood, such as can be obtained by finger prick. Because it is based 36 on a single soluble reagent, the test can be adapted very simply and rapidly to detect 37 antibodies against variants of the SARS-CoV-2, or conceivably against different pathogens. 38

HAT-field appears well suited to provide quantitative assessments of the serological 39 protection of populations as well as individuals, and given its very low cost, the stability of 40 the IH4-RBD reagent in the adapted buffer, and the simplicity of the procedure, could be 41 deployed pretty much anywhere, including in the poorest countries and the most remote 42 corners of the globe. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint 158 Similar data were obtained from four experiments.

Rather than diminishing the performance of HAT, we found that the presence of azide 161 improved its sensitivity: when HAT was performed in PBS-N3 rather than PBS, the titration 162 endpoints (figure 2A, blue circles) were shifted by one double dilution (DD), and this 163 occurred both with immune sera and with monoclonal antibodies. Addition of 1% BSA 164 sometimes improved sensitivity by another DD, but we only saw this in some experiments, 165

and not others. 166

To investigate the possible cause of the increased sensitivity of HAT in the presence of 167 sodium azide, we used fluorescence-activated cell sorting (FACS) to analyze the amount of 168 antibody bound to the RBCs at the end of the HAT. Dilution of the IH4-RBD reagent in PBS-169 N3 or in PBN resulted in a small increase in the amount of antibody bound to the surface of 170 the RBCs, but not to an extent that would explain the increased sensitivity ( Figure 2B ). We 171 postulate that the increased sensitivity due to the presence of azide may, instead, be due to 172

an 'ageing' effect on the RBCs (see Discussion) 173 174 175 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint IH4-RBD is very stable when diluted in PBN  176  For use in the field, it would be most convenient for the IH4-RBD reagent to be pre-177  distributed in the wells, raising the question of the stability of working dilutions of the  178  reagent, both in the cold and at ambient temperatures. To investigate the stability of IH4-179  RBD, we prepared aliquots of IH4-RBD at 2 g/ml in either PBS-N3 or in PBN, on various  180  dates over the course of 15 months and stored those aliquots at 4°C, room temperature (RT)  181 or 37°C. Those IH4-RBD aliquots of various ages were then used to perform HAT titrations of 182 the reagent in the presence of constant amounts of the CR3022 monoclonal antibody ( Figure  183 3). In some experiments, to evaluate more precisely the remaining activity of IH4-RBD after 184 incubation, we also quantified the amounts of antibodies bound to the surface of the RBCs 185 by using FACS (red numbers in Figure 3 ). 

By performing such experiments repeatedly, we found that IH4-RBD is remarkably stable 200 when diluted in PBN: no significant loss of activity was seen for any of the IH4-RBD PBN 201 dilutions kept for over a year at 4°C, and this was true for up to 6 months at room 202 temperature. At 37°C, we did see some progressive loss of activity, but this only resulted in 203 the loss of one DD in HAT sensitivity at 9.5 months (after 15 months, evaporation had caused 204

the loss of what was left of the aliquots kept at 37°C). 205

On the other hand, the activity of IH4-RBD dilutions prepared in PBS-azide were usually 206 already lower by one DD than those prepared in PBN on day zero. Furthermore, we 207 observed marked variability over time between the IH4-RBD dilutions prepared in PBS-azide 208 on different dates: some batches showed a drop of just one DD compared to the dilutions 209 prepared in PBN, and stayed stable for many weeks after this; for others, however, we 210

witnessed much more marked losses over time, dropping to undetectable levels after just a 211 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint few weeks, even for tubes kept at 4°C. In retrospect, we suspect that this variability may be 212

linked to the fact that, because the Covid-19 crisis had caused a penury of plasticware,  213  different types and brands of plastic tubes had to be used to prepare and stock the IH4-RBD  214  dilutions on different dates, and those different tubes probably had different protein-215  binding capacities, resulting in the variable loss of the diluted IH4-RBD protein.  216  217 The important take-home message we draw from this set of experiments is that, regardless 218 of the brand or type of plastic tubes used, as long as IH4-RBD was diluted in PBN, the activity 219 of the diluted stocks was always remarkably reproducible, and stable for over a year if kept 220

at is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint Incubation temperature had little or no discernable influence on the hemagglutination 245 endpoints (blue circles), with the possible exception of the wells containing the highest 246 concentration of IH4-RBD and very diluted sera, where incubation at 4°C resulted in a small 247 improvement in sensitivity when compared to the assays performed at RT or 37°C. 248 249 250

The HAT-field protocol 251

The observation that, in 2D titrations such as those shown in Figure 4 , the titration 252 endpoints were distributed in an almost linear fashion on an X-Y axis suggested to us that a 253 quantitative version of HAT might be developed by using dilutions of IH4-RBD rather than by 254 using serial dilutions of plasma or sera and donor RBCs. We have now devised such a 255 quantitative protocol, which only requires, for each test, one lancet, one plastic Pasteur 256 pipet, one plastic tube containing 300 l of PBS-2mM EDTA, 10 l of whole blood, and one 257 column of 8 conical wells on a 96-well plate, preloaded with 60 l/well of a range of 258 concentrations of IH4-RBD ( Figure 5 ). 259 260

The lancet is used to express a lentil-size drop of capillary blood from a clean fingertip of the 261 subject to be tested. The plastic Pasteur pipet is used to collect 10 l of that blood, which 262 corresponds to filling the first section of the pipet (the precise volume of blood collected is 263 not critical; it may vary by as much as 30% with no detectable influence on the results is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint above (Figure 4 ), increased sensitivity can be attained by the use of more IH4-RBD reagent, 284 but we found that another way to increase HAT sensitivity was to perform prolonged 285

incubations. After 5 hours, for example, we saw a very significant improvement in sensitivity, 286

with the titration endpoints increasing for most samples by 2 or 3 dilution points when 287 compared to those after 60 minutes, with fewer and fewer samples that were detected 288 positively by FACS remaining below the threshold value of 1 for HAT-field ( Figure S1 , first 289 line). 290 291

Such long incubations are, however, not practical for a test intended for use in field settings. 292

To overcome this problem, we found that centrifugation of the plates at 100g for 1 minute 293 increased sensitivity to a level equivalent, or even slightly superior to that of incubating the 294 plates for 5 hours. This centrifugation step, moreover, may be performed 15 minutes after 295 distributing the diluted blood in the plate, with similar results to those obtained if the plates 296

were centrifuged after 60 minutes incubation ( Figure S1 , second line). With access to the 297 means to centrifuge the assay wells (which can be achieved in adapted salad-spinners, see 298

Discussion), the HAT-field protocol can thus be completed in less than 30 minutes, which 299 would be compatible with performing it in certain field settings, for example in the context 300 of vaccination centers, to identify individuals with high levels of antibodies, who might not 301 need to be vaccinated or re-vaccinated. 302 303 304

. CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint Validation of the HAT-field protocol 305

To validate the performance of the HAT-field protocol, we used a panel of 60 EDTA whole-306 blood samples collected in early September from patients in the hematology department of 307

Toulouse University hospital. The samples were picked randomly from clinical samples left 308 over after the prescribed hematology analyses had been performed. At that time, over 85% 309 of the adult population had been vaccinated in France, and we thus expected a large 310

proportion of the samples to be seropositive against the S protein of SARS-CoV-2, albeit at 311 various levels. 312 313

The results obtained by HAT-field on these 60 whole blood samples were compared with 314 those obtained by testing the plasma from the same samples by using the original HAT 315 protocol with donor RBCs ( 

The very good correlation between the results of all three tests validates that the HAT-field 338 protocol can be used for quantitative assessment of the levels of antibodies contained in a 339

whole-blood sample in a single step, without the sophisticated equipment needed for the 340

Jurkat-S&R-flow test, and without needing to separate the RBCs from plasma or serum and 341 having access to RBCs from an O-donor, as in the experiment using the original HAT to 342 perform plasma titrations. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint HAT-field works with Delta-variant IH4-RBD 346

Our IH4-RBD reagent was designed to present the RBD sequence of the original Wuhan 347 variant (residues 340-538 of the S protein; (Townsend et al. 2021 . We therefore wanted to compare the results obtained with the IH4-RBD-Wuhan 352 reagent (used above) with a reagent that incorporates the two mutations in the Delta 353 variant, IH4-RBD-Delta. We tested the 60 blood samples with the IH4-RBD-Wuhan and IH4-354 RBD-Delta reagents in both the HAT-field and original HAT plasma titration assays. For most 355 samples, the scores obtained were one or two units higher when the Wuhan IH4-RBD 356 reagent was used than those with the IH4-RBD-Delta reagent ( Figure S3 ). This is consistent 357

with a previous report that, in vaccinated people, HAT titers obtained with the IH4-RBD-358

Delta tend to be lower than with the IH4-RBD-Wuhan (Jayathilaka et al. 2021) , and with the 359 fact that, at the time of our study, most people in the French population had antibodies due 360

to being vaccinated and not as a consequence of a previous infection by the SARS-CoV2 virus 361

(retrospective analysis of clinical information on our cohort of 60 blood samples revealed 362 that only three samples were from patients who had ever had a positive PCR test for SARS-363

CoV-2 (see data file and Figure S3 ). 364 365 366

Discussion 367

The aim of this project was to define a HAT protocol that could be used in the field. As such, 368

the HAT-field protocol needed to work with satisfactory sensitivity on capillary blood, and to 369 involve no specialized laboratory equipment such as adjustable pipets and disposable tips. In 370 the course of our efforts, we discovered that i) the use of PBN results in markedly improved 371

HAT robustness and sensitivity ii) HAT sensitivity is markedly improved by prolonged 372 incubations (or by brief low-speed centrifugation), albeit with a parallel drop in specificity iii) 373 quantification could be achieved by titrating the IH4-RBD reagent rather than the plasmas or 374 sera. Incidentally, we realized recently that such an approach of titrating the RBC-binding 375 reagent had been suggested previously for an HIV serodiagnostic test (Kemp et al. 1988 ). 376 377

PBN is a buffer containing both 1% BSA and azide, which has several concomitant 378 advantages: i) Used as a dilution buffer for the IH4-RBD, it blocks the reagent's nonspecific 379 adsorption to plastic, and results in its much improved stability over time, even if kept out of 380 the cold. ii) The conjoint action of azide and BSA results in increased sensitivity, probably 381 because they both improve the settling of the RBCs at the bottom of the wells. iii) In 382 experiments which involve the use of O-RBCs, for example when using HAT to titrate 383 plasmas or sera, the use of whole blood (or the addition of 1% seronegative plasma or 384 serum) is no longer necessary when PBN is used to prepare a suspension of washed O-RBCs. 385 We feel that this advantage is quite significant since most blood donors in the population 386 have now become seropositive because of vaccinations. 387 388

As we have seen, the improvement of HAT sensitivity provided by prolonging incubations up 389

to 5 hours can be very advantageously replaced by a brief step of centrifugation at 100g, 390

which can be performed after only 15 minutes of incubation. The need for a centrifuge with 391 the capacity to spin 96 well plates would, however, rather preclude the possibility of 392 performing HAT in the field. But accelerations of 100g are in the range of those attained by 393 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint hand-driven centrifuges such as salad spinners. We have investigated the possibility of using 394 this type of centrifuge for spinning 96 well plates after just 15 to 20 minutes of incubation, 395

but have found that this only works for the central 2 columns of a 96 well plate because the 396

RBCs in the outer columns are pushed to the outside of the wells. Whilst it is hard to 397 conceive that hand-driven centrifuges with the capacity to spin 96 well plates in swinging-398 out trays could become part of the equipment enabling the use of HAT in the field, a rather 399 simple solution would be to design plastic strips of conical wells for individual tests. Using 400 very simple adapters, those purposefully designed sets of wells could then be spun in hand-401 driven centrifuges of the salad spinner type. The design, and manufacture, of such 402 disposable strips of wells, which would necessarily require the involvement of an industrial 403 partner, was, however, well beyond the means of this study. 404 405

One important consideration about performing centrifugation at the end of a HAT assay is 406 that, whilst this works very well with RBCs contained in whole blood samples, or with 407

washed RBCs from freshly collected blood, we found that it can become problematic with 408

RBCs that have been stored at 4°C for more than a week. Over time, stored RBCs will indeed 409 progressively lose their capacity to teardrop, which can, incidentally, result in a slight 410 improvement of the apparent sensitivity of HAT assays performed under simple gravity. 411

But, if submitted to accelerations of 100g, we have found that such "aged" RBCs will form 412 compact pellets that will fail to teardrop, even upon prolonged tilting of the plate. (of note, 413

this is also the case for RBCs that have been kept in azide for a few hours. Preparing 414

suspensions of RBCs in PBN should thus be done just before performing the HAT assays). 415 416

When performing HAT in PBN compared to PBS, we observed an increase in sensitivity which 417

we suspect is most probably due to an improved sedimentation of the RBCs, with both azide, 418

and BSA, contributing to the formation of more compact pellets at the bottom of the V-419

shaped wells. Regarding the role of azide, we postulate that, by blocking the metabolism of 420 the RBCs, it probably increases their density and consequently their sedimentation. 421

Regarding the beneficial role of facilitating the sedimentation of RBCs, this is something that 422

Weggmann and Smithies had recognized soon after their initial description of the microtiter 423 hemagglutination method, and for which they had proposed using paraffin-coated plates as 424 an improvement (Wegmann and Smithies 1968). We feel, however, that the use of PBN as 425 the diluting buffer of the IH4-RBD reagent is much simpler than that of paraffin-coated 426 plates, and, as will be seen below, this has several other advantages, including the 427 improvement of the stability of the reagent over time. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint

In their original paper, Wegmann and Smithies had described using incubations of 4 to 6 441 hours as their standard protocol, and suggested that a brief step of centrifugation could be 442 used as an alternative (Wegmann and Smithies 1966) . For the record, during the initial 443 stages of this study, we had made several attempts to use centrifugation, but we did not 444 have access to whole blood samples at the time. We were thus using O-RBCs which had 445 often been stored at 4°C for up to several weeks, and had initially given up on centrifugation 446

because the aged RBCs we were using failed to teardrop after centrifugation. Incidentally, in 447 that same paper, Wegmann and Smithies also suggested using BSA as an alternative to 448 serum or plasma to promote better RBC settling patterns. They were, however, 449 recommending using BSA at 0.22% which we found to be less effective than 1% to block the 450 adsorption of the IH4-RBD reagent to plastic. 451 452

Once we had found that the use of centrifugation, combined to that of PBN as a buffer, On the graph on the left of figure 6 , which compares the scores of titrations by standard HAT 462

to those obtained with HAT-field, most points are sitting above the median line, with several 463

points (corresponding to 10 samples, see data file) not scoring positive by HAT-field (i.e. a 464 score < 1) whilst being positive by standard HAT titration (i.e. score ≥ 1). In the conditions 465 used in this study, the HAT-field protocol was thus markedly less sensitive than the 466 optimized standard HAT approach, which can be explained by the conjunction of 4 factors: 467 a) For titrations by standard HAT, we used plasmas at 1/50 as the highest concentration. In 468 other words, we used 2 µl of plasma per well, to react against 0.3 µl of RBCs. The plasma to 469 RBC ratio was thus six times more than in HAT-field, where there are roughly equivalent 470 volumes of RBCs and plasma, and this ratio of 1 cannot be altered since, in HAT-field, the 471 blood samples are simply diluted before performing the assay. On this subject, we have 472

found that increasing the amount of whole blood per well (in other words using blood that is 473 less dilute) has very little influence over the HAT-field results, and, if anything, adding more 474 blood can sometimes reduce the sensitivity, albeit never by more than 1 dilution. 475 b) Titrations for figure 6 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint On the right panel of figure 6 , one finds four samples that scored positive by standard HAT, 489

whilst the staining values in the Jurkat-S&R-flow test were in the doubtful zone between 10 490 and 40, and our view is that those samples probably contained some antibodies reacting 491 specifically against the SARS-CoV-2 spike protein, and their more effective detection by 492 hemagglutination than by FACS staining may be due to relatively high proportions of IgAs or 493

IgMs. This is indeed reminiscent of the observation reported in our first paper that HAT 494 could detect antibody responses during very early SARS-CoV-2 infections before CLIA 495 (Townsend et al. 2021 ). Incidentally, although this is not something that we have yet 496 managed to document formally, we noticed that the samples which contain sizeable 497 amounts of IgMs and/or IgAs often reach higher HAT scores than expected from the FACS 498 results obtained with the pan-human Ig secondary antibody, with even higher scores by 499 plasma dilutions than in HAT-field (see data file). Of note, for sample 19, which was a false 500 positive and gave very high titers against that IH4 alone, FACS analysis performed after the 501 HAT assay showed that the human antibodies bound to the IH4-coated RBCs were 502 predominantly IgMs (data not shown). 503 504

For one sample (n° 48 in data file), indicated by an orange symbol with a red circle in Figure  505 6, the result of Jurkat-S&R-flow test was 44.84, i.e. just above the threshold value which is 506 arbitrarily set to 40. This sample only led to partial hemagglutination at 1/50 in the standard 507

HAT, but showed reactivity against the IH4 nanobody alone with an endpoint at 1/200 after 508 centrifugation (score 3). We thus surmise that this sample does contains either very low or 509 no specific anti-SARS-CoV-2 antibodies, which provides a justification for maintaining the 510

Jurkat-S&R-flow test threshold at its current value. 511 512

As in all biological tests, increasing the sensitivity will almost unavoidably lead to an increase 513 in the proportion of false positives. It is thus not surprising that, with the gain of sensitivity 514 of HAT afforded by the combined use of PBN and spinning, the proportion of samples being 515 detected as showing some reactivity against the IH4 nanobody should be higher than the 1 516 to 2% that were originally detected with the standard HAT protocol in various cohorts 517 (Townsend et In our current cohort, with the HAT-field protocol, reactivity against the IH4 moiety was 520 detected in 3% of samples (2 out of 60) after one hour under normal gravity, and climbed to 521 8 % (5 out of 60) after spinning. With the more sensitive protocol used for plasma titrations, 522 5 samples (8%) reacted against the IH4 nanobody after one hour under simple gravity, but 523 this number climbed to 12 (20% of samples) after spinning. If the HAT-field test was ever to 524 be used in a clinical context, the results would be invalidated for those samples found to 525 react with the IH4 alone, and with such high frequencies as we have observed in our small 526 cohort, this could be a significant problem. An alternative would be to perform, from the 527 start, systematic parallel titrations of the IH4-BRD and IH4 alone reagent, in order to identify 528 samples which react markedly better on IH4-RBD than on IH4 alone. This could be achieved 529 either by using 20 µl of blood diluted into 600 µl to distribute in two set of 8 wells, which 530 would be quite easy since 20 µl corresponds to the second section on the plastic Pasteur 531 pipets. Alternatively, titrations of the two reagents could be carried out over just 4 wells 532 each, with larger dilution factors (e.g. 10 fold) between wells. 533 534 535 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint

In future, to reduce the proportion of false positives due to reactivities with the IH4 moiety, 536 it may be interesting to investigate if the nanobody, which is of camel origin, could be 537 somewhat "humanized" by site-directed mutagenesis without losing its capacity to bind to 538 human glycophorin. Alternatively, the use of different antibodies binding to glycophorin, 539

such as nanobodies derived from other species, or mAbs such as the one described by Kemp 540 and colleagues (Kemp et al. 1988 ; Wilson et al. 1991 ) could also be explored as an 541

alternative. 542 543

Two recent reports have described that HAT could be performed on cards rather than in V-544

shaped wells, with semi-quantitative results being obtained in minutes, which was made 545 possible by the use of much higher amounts of the IH4-RBD reagent than when HAT is 546 performed in V-shaped well ( We have shown that the HAT-field approach, which uses a single drop of capillary blood, can 555 provide in a single step, a quantitative measurement of the antibodies against the viral RBD, 556

which are those endowed with neutralizing activity. Such a test could prove very useful for 557

identifying individuals in need of a vaccine boost (or a primary injection). Given its very low 558 cost, the stability of the IH4-RBD reagent, and the simplicity of the procedure, HAT-field 559 should be well suited to be performed pretty much anywhere, including in the poorest 560 countries and the most remote corners of the globe. Given that HAT has already been 561 successfully adapted to detect antibodies against the RBD of several SARS-CoV2 variants 562 (Ertesvåg et is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint were kept frozen as aliquots. Those were then used to prepare 100X stocks in either PBS or 608 PBN, which were kept frozen, and kept a 4°C after thawing for up to a few weeks. 609 610

To study the stability of the IH4-RBD reagent over time, working solutions at 2 µg/ml in 611 either PBS-azide or in PBN were prepared from 100X PBS stocks at various time points over 612 the course of a whole year. Three aliquots of 500 µl each were then set aside from those 613 working stocks, to be kept either at 4°C, at room temperature or at 37°C in a tissue culture 614

incubator. The activity of those aliquots of working stocks was then evaluated at regular 615 intervals by performing titrations of the IH4-RBD reagent against either the CR3022 616 monoclonal antibody diluted to a final concentration of 100 ng/ml, or various immune sera 617 diluted to give similar endpoint to those obtained with CR3022. 618 619

When comparing the reactivities against the Wuhan and Delta IH4-RBD reagents, we 620 ascertained that we were using working concentrations of the two reagents with 621 comparable activities by performing titrations with two monoclonals, EY6A or CR3022, which 622 recognize a binding site not affected by the two mutations carried by the RBD of the Delta 623 viral lineage, and found the Wuhan and Delta reagents to have indistinguishable 624

hemagglutinating activities under those conditions. 625 626 627

. CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. Human samples 641

The 60 whole blood samples were collected, regardless of gender, in the course of the 642 month September 2021. Those were anonymized within 24 hours of collection, transferred 643 from the hospital to the research lab, and kept at room temperature until being used for 644

HAT assays within 24 hours (i.e. less than 48 hours after blood samples were collected). In 645 trial experiments, we had found that such samples could be stored for up to 5 days without 646 any noticeable difference in the performance of the HAT tests. 647 648

After the whole blood samples had been used for HAT-field assays, the tubes were then 649 spun, the plasmas harvested into fresh tubes, and sodium azide added to 3 mM final. Those 650 harvested plasmas were kept at 4°C until they were used to perform the Jurkat-S&R-flow 651 tests and HAT assays for plasma titrations. 652 653

The identities, clinical conditions and Covid status (PCR or positive serology) were unknown 654 to the person performing the HAT experiments and Jurkat-S&R-flow tests. 655 656

Blood samples from O-donors (6 ml EDTA tubes) were obtained every few weeks from the 657 EFS (Toulouse blood bank). Whilst whole blood is best kept at room temperature (i.e. 658 between 20 and 25 °C), and can then only be used for HAT assays for up to 5 or 6 days, 659

washed red blood cells can be kept for several weeks, as long as they have been separated 660 from the white blood cells, and are kept at 4°C in the right buffer (in our case Alsever's 661 solution, Sigma A3551). 662 663

For preparing RBCs for storage at 4°C, we used the following standard protocol. The EDTA 664 collection tube is spun at 1000g for 20 minutes with no refrigeration, and the centrifµge 665 brake set to 2 /9. The plasma is collected into a separate sterile tube and a total of 8 ml of 666 sterile PBS used to resuspend the cells and transfer them to a 15 ml tube, on top of a 3 ml 667 cushion of lymphocyte separation medium ( Corning Ref 25-072-CV ). This tube is then spun 668 once more at 1000g for 20 minutes with no refrigeration, and the centrifµge brake set to 2 669 /9. The supernatant, including the ring of white blood cells, is aspirated and discarded. The 670

RBC pellet is then washed twice with 8 ml sterile PBS, once in 8 ml Alsever's solution, before 671

adding two volumes of Alsever's solution to the one volume of packed RBCs. This tube of 672

RBCs (at 30% v/v) can then be stored at 4°C, and used for HAT assays for several weeks. 673

After a week of storage, however, we found that the RBCs progressively tend to lose their 674 capacity to teardrop after spinning. 675 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint If whole blood from an O-donor was needed for experiments (e.g. as in Figure 2 ), 100-200 µl 676

were transferred to a separate sterile tube before performing the above procedure, and this 677 tube was kept at room temperature for a maximum of 4 days. For experiments such as that presented in Figure 1 , tubes of the appropriate 2X stocks 702 containing either the RBCs and the antibodies, or the IH4-RBD reagent were prepared to be 703 mixed 50/50 in each well. 704 705

For titration experiments, we prepared stocks containing RBCs and the appropriate amount 706 of the reagent to be kept constant (either the IH4-RBD reagent at 1 µg/ml or IH4 alone at 0.5 707 µg/ml for plasma titrations, or the appropriate antibody dilution for IH4-RBD titrations). 100 708 µl of those stocks were then distributed per well, and 200 µl for the wells of the first row. 709

The reagents to be titrated were then added to each of the wells of the first row, and a 710 multi-channel pipet was then used perform the serial dilutions by successive transfer of 100 711 µl to the wells of the adjacent row, with thorough mixing by pipetting gently up and down at 712 least 6 times at each diluting step. 713 714

A similar method was used to perform the 2D titrations presented in figure 4 , filling columns 715 of wells with stocks of IH4-RBD serially diluted with the appropriate suspension of RBCs, and 716

proceeding in a second stage to perform serial dilutions of the antibodies in rows, as 717 described above. 718 719 720 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint HAT-field assays 721

The optimized procedure we have arrived to and used for this study is based on using 7 722 serial dilutions of the IH4-RBD reagent. Rather than double dilutions, we elected to use 3.16 723 as a dilution factor between adjacent wells. This not only allows to cover a larger range of 724 IH4-RBD concentrations, but because 3.16 is the square root of 10, two successive dilutions 725 conveniently correspond to a factor of 10. For the 60 samples of the cohort used in our study, because we were running sets of parallel 741

HAT-field assays with either the IH4-RBD-Wuhan or IH4-RBD-Delta reagents, we performed 742 both types of negative controls by using PBN as a negative control in the plates for the 743

Wuhan HAT-field assays, and IH4 alone as a negative control in the plates for the Delta HAT-744 field assays. As discussed above, we found that the negative controls using the IH4 alone 745

were much more informative. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint clumping is to analyze those samples that are just one or two dilutions above the endpoint. 808

But this will mean that all samples will not all have been stained with the same amounts of 809 reagent and consequently that the staining levels cannot be compared with one another. 810 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint Alternatively, the problem can also be avoided by keeping the concentrations of the IH4-RBD 811 below 100 ng/ml, but this will result in a further reduction of the sensitivity for the samples 812 with low levels of antibodies. This project was initially funded by a private donation, and subsequently by the ANR grant 822

HAT-field to EJ. 823 824

Acknowledgements 825

We are particularly grateful to the following people: Alain Townsend, Tiong Kit Tan, Pramila 826

Rijal, who contributed the various materials detailed in the above table, and to Carol 827

Featherstone for copy editing. We also gratefully acknowledge the contributions of 828

Marianne Navarra, for her help in setting up the agreement with the hospital; Emmanuelle 829

Naser and Pénélope Viana from the IPBS flow cytometry facility for their assistance; the staff 830 of the Toulouse EFS (Etablissement Français du Sang) for the provision of O-blood samples; 831

Florence Abravanel and Jacques Izopet for providing immune sera from convalescent Covid 832 patients, and Eric Vallée for the experiments he carried out very early on in the course of the 833 pandemic to compare the performance of HAT with those of the lateral flow assays. 834 . CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint comparisons between those sets are presented on figures 6 and S1-3, it was not 840 practical to provide comparisons for all the possibly interesting combinations. With 841 the sets of data provided as an Excel file, interested reader wanting to explore other 842

comparisons not provided here can easily perform those. 843 844

The data sets provided are as follows: 845 846

Column A Sample numbers HAT-field scores (starting with IH4-RBD at 3.16 µg/ml) Each score increment corresponds to dilution of IH4-RBD by a factor of 3.16 B

IH4-RBD Wuhan after 60' under normal gravity C IH4-RBD Wuhan after 60' + 1' spin @ 100g D IH4-RBD Delta after 60' under normal gravity E IH4-RBD Delta after 60' + 1' spin @ 100g F IH4-RBD Wuhan 1' spin @ 100g after 15' incubation G IH4-RBD Delta 1' spin @ 100g after 15' incubation H IH4-RBD Wuhan after 1 hour under normal gravity I IH4-RBD Wuhan after 3 hours under normal gravity J IH4-RBD Wuhan after 5 hours under normal gravity K IH4-RBD Delta after 1 hour under normal gravity L IH4-RBD Delta after 3 hours under normal gravity M IH4-RBD Delta after 5 hours under normal gravity Titrations on O-RBCs (using 1 µg/ml IH4-RDB) Starting with plasmas @1/50 (score 1) Each score increment corresponds to one further double dilution of plasma N IH4-RBD Wuhan after 60' under normal gravity O IH4-RBD Wuhan after 60' + 1' spin @ 100g P IH4-RBD Delta after 60' under normal gravity Q IH4-RBD Delta after 60' + 1' spin @ 100g Reactivities on IH4 alone (performed only on those samples which had shown reactivity on IH4 alone @ 1.6 µg/ml ) in the initial whole blood screen HAT-field scores (starting with IH4 alone at 1.6 µg/ml) Each score increment corresponds to dilution of IH4 alone by a factor of 3.16 R IH4 alone after 60' under normal gravity S IH4 alone after 60' under normal gravity + 1' spin @ 100g Titrations on O-RBCs (using 0.5 µg/ml IH4 alone) Starting with plasmas @1/50 (score 1) Each score increment corresponds to one further double dilution of plasma T IH4 alone after 60' under normal gravity U IH4 alone after 60' under normal gravity + 1' spin @ 100g Results of the Jurkat-S&R-flow test (GMFI Jurkat-S -GMFI Jurkat-R )

. CC-BY-NC 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. Figure S1 : Influence of the incubation times on HAT-field scores 852 853 Figure S2 : Spinning of plates for plasma titrations after 60 minutes incubation under normal 854 gravity also greatly increases sensitivity 855 856 Figure is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 14, 2022. ; https://doi.org/10.1101/2022.01.14.22268980 doi: medRxiv preprint

Haemagglutination Test for Predicting Immunity to Sars CoV-2 Variants of Concern

V(H)H (nanobody) directed against human 870 glycophorin A: a tool for autologous red cell agglutination assays

Comparison of kinetics of immune 873 responses to SARS-CoV-2 proteins in individuals with varying severity of infection and 874 following a single dose of the AZD1222

Seroprevalence of SARS-CoV-2 876 Infection in the Colombo Municipality Region, Sri Lanka. Frontiers in public health 9

Immune responses to a 879 single dose of the AZD1222/Covishield vaccine in health care workers

Autologous red cell agglutination 882 assay for HIV-1 antibodies: simplified test with whole blood

Principles, problems, and strategies in the use of 885 antigenic mixtures for the enzyme-linked immunosorbent assay

A Hemagglutination-Based Semiquantitative 888 Test for Point-of-Care Determination of SARS-CoV-2 Antibody Levels

Comparability of six different 891 immunoassays measuring SARS-CoV-2 antibodies with neutralising antibody levels in 892 convalescent plasma: from utility to prediction

A simple, sensitive and quantitative 894 FACS-based test for SARS-CoV-2 serology in humans and animals

Human monoclonal antibody 896 combination against SARS coronavirus: synergy and coverage of escape mutants

A rapid and affordable point of 899 care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial 900 intelligence interpretation

A haemagglutination test for rapid detection of 902 antibodies to SARS-CoV-2

A simple hemagglutination system requiring small 904 amounts of red cells and antibodies

Improvement of the microtiter hemagglutination 906 method

Rapid whole blood assay for HIV-1 908 seropositivity using an Fab-peptide conjugate

Structural basis for the neutralization 911 of SARS-CoV-2 by an antibody from a convalescent patient